Shoulda gone with VitroGro, page-13

it is I think of interest and instruction to view the Dermagraft trial outcomes of 2013.
http://clinicaltrials.gov/ct2/show/results/NCT00909870#all
When TIS executes the controlled studies that will be required of them for reimbursement within EU and US FDA regulatory clearance it would appear that it is complete healing greater than 50% by week 12 and 70% by week 16 with a p<0.05 comparisioned to control to be achieved for approval.

there is of yet there is no posting I can find of details of S&N HP802-247 trial

Was there at the GM discussion of controlled studies to support application for reimbursement? or as P2 for FDA?